Battle Bias & Build Trust: How to Increase Transparency in Clinical Research
Who Should Attend
This course is open to students, principal investigators, clinicians, project managers, research coordinators, and anyone interested in clinical research.
Only about half of clinical trials run globally have ever been publicly registered and reported. This finding was confirmed by NEJM’s Anderson et al., 2015, where Dr. Robert Califf, our FDA commissioner, reported that only 13% of clinical trials comply with the FDAAA 2007. This causes bias in the medical literature, which undermines both medicine and research. When the media reports on this lack of transparency in medical research, we risk losing the trust of patients and the public.
- Describes the current state of clinical trial transparency in the US, including relevant policies
- Outlines concrete steps for investigators and academic leaders to increase transparency in their research and at their institution
- Introduces strategies and resources for raising awareness and overcoming barriers to transparency
- Identifies opportunities for investigators to advocate for transparency through training and support from AllTrials USA
April Clyburne-Sherin, trained Epidemiologist & Methodologist, Campaign Manager for AllTrials USA at Sense About Science USA, working to advance research transparency through advocacy and training.
One 3 hour session. First time offered!
July 26, 2017 | 12:00-3:00 PM | Location: Health Sciences Campus (HSC), Zilkha Neurogenetic Institute, Herklotz Seminar Room, Room 112.
To register, please RSVP with CODE: Clinical
For information about workshops, contact the office at 213-740-6709.